Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor.
Fujiwara H, Kawada H, Matsushita K, Hamada H, Ozaki A, Inoue H, Yoshimitsu M, Kukita T, Arimura K, Ohtsubo H, Uozumi K, Arima N, Tei C. Fujiwara H, et al. Among authors: yoshimitsu m. Int J Hematol. 2005 Nov;82(4):357-61. doi: 10.1532/IJH97.05047. Int J Hematol. 2005. PMID: 16298831
High prevalence of human T-lymphotropic virus type I carriers among patients with myelodysplastic syndrome refractory anemia with excess of blasts (RAEB), RAEB in transformation and acute promyelocytic leukemia.
Inoue H, Matsushita K, Arima N, Hamada H, Uozumi K, Ozaki A, Akimoto M, Kawada H, Kukita T, Yoshimitsu M, Matsumoto T, Tei C. Inoue H, et al. Among authors: yoshimitsu m. Leuk Lymphoma. 2008 Feb;49(2):315-21. doi: 10.1080/10428190701799019. Leuk Lymphoma. 2008. PMID: 18231919
Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions.
Yoshimitsu M, Fujiwara H, Ozaki A, Hamada H, Matsushita K, Arima N, Tei C. Yoshimitsu M, et al. Int J Hematol. 2008 Oct;88(3):331-335. doi: 10.1007/s12185-008-0150-z. Epub 2008 Aug 12. Int J Hematol. 2008. PMID: 18696183
Recombinant human soluble thrombomodulin for the treatment of hepatic sinusoidal obstructive syndrome post allogeneic hematopoietic SCT.
Nakamura D, Yoshimitsu M, Kawada H, Inoue H, Kuroki T, Kaieda T, Fujino S, Hamada H, Suzuki S, Matsushita K, Uozumi K, Arima N. Nakamura D, et al. Among authors: yoshimitsu m. Bone Marrow Transplant. 2012 Mar;47(3):463-4. doi: 10.1038/bmt.2011.103. Epub 2011 May 9. Bone Marrow Transplant. 2012. PMID: 21552299 No abstract available.
Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N. Kozako T, et al. Among authors: yoshimitsu m. Hum Immunol. 2011 Nov;72(11):1001-6. doi: 10.1016/j.humimm.2011.07.308. Epub 2011 Aug 2. Hum Immunol. 2011. PMID: 21851845
222 results